Skip to menu Skip to content Skip to footer
The University of Queensland
  • Study
  • Research
  • Partners and community
  • About
Frazer Institute
  • Home
  • About
    • About
    • News
    • Our people
    • History
    • Our supporters
    • The Translational Research Institute
    • Events
  • Research
    • Research
    • Research themes
    • Research centres
    • Research by disease
    • Facilities and support services
    • Innovation and commercial development
  • Study
    • Study
    • Undergraduate
    • Honours
    • Higher Degree by Research
    • Scholarships
    • Visiting Research Students
    • Why should I do my research project at Frazer Institute?
  • Laboratory to patient
    • Laboratory to patient
    • Clinical trials
    • Clinical research facilities
  • Community and alumni
  • Donate now
  • Contact
  • Study
  • Research
  • Partners and community
  • About
  • UQ home
  • News
  • Events
  • Give
  • Contact
  • UQ home
  • News
  • Events
  • Give
  • Contact
Frazer Institute
  • Home
  • About
    • News
    • Our people
    • History
    • Our supporters
    • The Translational Research Institute
    • Events
  • Research
    • Research themes
    • Research centres
    • Research by disease
    • Facilities and support services
    • Innovation and commercial development
  • Study
    • Undergraduate
    • Honours
    • Higher Degree by Research
    • Scholarships
    • Visiting Research Students
    • Why should I do my research project at Frazer Institute?
  • Laboratory to patient
    • Clinical trials
    • Clinical research facilities
  • Community and alumni
  • Donate now
  • Contact

Miss Sheena Daignault

PhD student
Frazer Institute
s.daignault1@uq.edu.au

Publications

Journal Articles (7)
Conference Papers (18)
Thesis (1)

Journal Articles

Morris, Elysse K., Daignault-Mill, Sheena, Stehbens, Samantha J., Genovesi, Laura A. and Lagendijk, Anne K. (2023). Addressing blood-brain-tumor-barrier heterogeneity in pediatric brain tumors with innovative preclinical models. Frontiers in Oncology, 13 1101522, 1-9. doi: 10.3389/fonc.2023.1101522
Chauvistré, Heike, Shannan, Batool, Daignault-Mill, Sheena M., Ju, Robert J., Picard, Daniel, Egetemaier, Stefanie, Váraljai, Renáta, Gibhardt, Christine S., Sechi, Antonio, Kaschani, Farnusch, Keminer, Oliver, Stehbens, Samantha J., Liu, Qin, Yin, Xiangfan, Jeyakumar, Kirujan, Vogel, Felix C. E., Krepler, Clemens, Rebecca, Vito W., Kubat, Linda, Lueong, Smiths S., Forster, Jan, Horn, Susanne, Remke, Marc, Ehrmann, Michael, Paschen, Annette, Becker, Jürgen C., Helfrich, Iris, Rauh, Daniel, Kaiser, Markus ... Roesch, Alexander (2022). Persister state-directed transitioning and vulnerability in melanoma. Nature Communications, 13 (1) 3055, 3055. doi: 10.1038/s41467-022-30641-9
Proctor, Martina, Gonzalez Cruz, Jazmina L., Daignault-Mill, Sheena M., Veitch, Margaret, Zeng, Bijun, Ehmann, Anna, Sabdia, Muhammed, Snell, Cameron, Keane, Colm, Dolcetti, Riccardo, Haass, Nikolas K., Wells, James W. and Gabrielli, Brian (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers, 13 (15) 3733, 1-19. doi: 10.3390/cancers13153733
Oo, Zay Yar, Proctor, Martina, Stevenson, Alexander J., Nazareth, Deborah, Fernando, Madushan, Daignault, Sheena M., Lanagan, Catherine, Walpole, Sebastian, Bonazzi, Vanessa, Škalamera, Dubravka, Snell, Cameron, Haass, Nikolas K., Larsen, Jill E. and Gabrielli, Brian (2019). Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine. Molecular Oncology, 13 (7) 1878-0261.12497, 1503-1518. doi: 10.1002/1878-0261.12497
Oo, Zay Yar, Stevenson, Alexander J., Proctor, Martina A., Daignault, Sheena M., Walpole, Sebastian, Lanagan, Catherine, Chen, James, Skalamera, Dubravka, Spoerri, Loredana, Ainger, Stephen, Sturm, Richard A, Haass, Nikolas K and Gabrielli, Brian (2018). Endogenous replication stress marks melanomas sensitive to CHEK1 inhibitors in vivo. Clinical Cancer Research, 24 (12), 2901-2912. doi: 10.1158/1078-0432.CCR-17-2701
Skalamera, Dubravka, Dahmer-Heath, Mareike, Stevenson, Alexander J., Pinto, Cletus, Shah, Esha T., Daignault, Sheena M., Said, Nur Akmarina B. M., Davis, Melissa, Haass, Nikolas K., Williams, Elizabeth D., Hollier, Brett G., Thompson, Erik W., Gabrielli, Brian and Gonda, Thomas J. (2016). Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer. Oncotarget, 7 (38), 61000-61020. doi: 10.18632/oncotarget.11314
Beaumont, Kimberley A., Hill, David S., Daignault, Sheena M., Lui, Goldie Y. L., Sharp, Danae M., Gabrielli, Brian, Weninger, Wolfgang and Haass, Nikolas K. (2016). Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells. Journal of Investigative Dermatology, 136 (7), 1479-1489. doi: 10.1016/j.jid.2016.02.805

Conference Papers

Morris, Elysse, Daignault-Mill, Sheena, Ju, Robert J., da Silva, Jason, Gordon, Emma, Wainwright, Brandon, Stehbens, Samantha, Genovesi, Laura and Lagendijk, Anne (2023). Uncovering Dynamic Changes In Medulloblastoma Associated Vasculature In Zebrafish. 2023 Pediatric Neuro-Oncology Research Conference, Washington, DC United States, 22-24 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/neuonc/noad073.274
Spoerri, L., Tonnessen, C., Beaumont, K., Hill, D., Jurek, R., Gunasingh, G., Daignault, S. M., Vanwalleghem, G., Weninger, W., Scott, E. and Haass, N. K. (2019). MITF-mediated extracellular matrix changes control intratumour heterogeneity in melanoma. 49th Annual ESDR Meeting, Bordeaux, France, 18-21 September 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2019.07.709
Daignault, S. M., Spoerri, L., Ju, R. J., Stehbens, S. J., Hill, D. S., Dolcetti, R. and Haass, N. (2019). Enforcing cellular stress promotes apoptotic and immunogenic responses in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/exd.13859
Daignault, S. M., Ju, R., Spoerri, L., Stehbens, S. J., Hill, D. S., Gabrielli, B., Dolcetti, R. and Haass, N. K. (2019). Bortezomib-induced immunogenic cell death enhances immune response in melanoma. Society for Investigative Dermatology (SID) Meeting, Chicago, IL United States, 8-11 May 2019. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2019.03.907
Daignault, S. M., Ju, R. J., Spoerri, L., Stehbens, S. J., Dolcetti, R. and Haass, N. K. (2019). Bortezomib induces immunogenic cell death in melanoma and enhances immune responses in vivo. 49th Annual Meeting of the European Society for Dermatological Research (ESDR), Bordeaux, France, 18-21 September, 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2019.07.506
Daignault, S. M., Hill, D. S., Spoerri, L., Stehbens, S., Weninger, W., Gabrielli, B., Dolcetti, R. and Haass, N. K. (2018). Targeting cell cycle phase-specific drug sensitivity for melanoma therapy. 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF), Zurich, Switzerland, 7-10 March 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Haass, N. K., Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Daignault, S. M., Ahmed, F., Smith, A. G. and Weninger, W. (2017). Microphthalmia-associated transcription factor regulates dynamic melanoma heterogeneity. 47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Salzburg, Austria, 27-30 September 2017. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2017.07.726
Haass, N., Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Daignault, S. M., Gabrielli, B. and Weninger, W. (2017). Cell cycle-tailored targeting of metastatic melanoma: challenges and opportunities. Australasian College of Dermatologists 50th Annual Scientific Meeting, International Convention Centre, Sydney, NSW Australia, 6-9 May 2017. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.20_12652
Stehn, J. R., Stevenson, A., Spoerri, L., Daignault, S. M., Gabrielli, B., Eiffe, E., Gunning, P. W. and Haass, N. (2016). Developing a new melanoma drug. HOBOKEN: WILEY-BLACKWELL.
Beaumont, K., Hill, D., Daignault, S., Sharp, D., Gabrielli, B., Weninger, W. and Haass, N. (2016). Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells. Annual Meeting of the Society-for-Investigative-Dermatology (SID), Scottsdale, AZ, United States, 11-14 May 2016. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2016.02.695
Tonnessen, C. A., Beaumont, K. A., Spoerri, L., Hill, D. S., Jurek, R. J., Daignault, S. M., Ahmed, F., Fane, M., Smith, A., Weninger, W. and Haass, N. K. (2016). MITF regulates cell adhesion and subcompartment-specific distribution of differentially cycling melanoma cells. 43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF), Vienna Austria, Mar 10-12, 2016. HOBOKEN: WILEY-BLACKWELL.
Hill, D. S., Beaumont, K. A., Daignault, S. M., Sharp, D. M., Gabrielli, B., Weninger, W. and Haass, N. K. (2016). Cell cycle phase determines efficacy of bortezomib, temozolomide and MAPK inhibitor-induced apoptosis in melanoma. 43rd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung-e-V (ADF), Vienna Austria, Mar 10-12, 2016. HOBOKEN: WILEY-BLACKWELL.
Ahmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584
Daignault, S. M., Tonnessen, C. A., Ahmed, F., Spoerri, L. and Haass, N. K. (2016). MITF modifies invasion and characteristics of the epithelial to mesenchymal transition in melanoma. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.
Tonnessen, Crystal A., Beaumont, Kimberley A., Hill, David S., Daignault, Sheena M., Anfosso, Andrea, Jurek, Russell J., Weninger, Wolfgang and Haass, Nikolas K. (2015). MITF regulates proliferative subpopulation tumor architecture and modifies invasion and characteristics of the epithelial to mesenchymal transition within melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, United States, 18-22 April 2015. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-1420
Hill, D. S., Beaumont, K. A., Daignault, S. M., Anfosso, A., Sharp, D. M., Gabrielli, B., Lovat, P. E., Weninger, W. and Haass, N. K. (2015). Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicity. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, Mar 05-07, 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623
Hill, D. S., Beaumont, K. A., Daignault, S. M., Anfosso, A., Lovat, P. E., Weninger, W. and Haass, N. K. (2015). Making stressed melanoma self-destruct. Australasian College of Dermatologists 48th Annual Scientific Meeting, Adelaide, Australia, 16 May, 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337
Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Anfosso, A., Daignault, S. M., Fane, M., Jurek, R. J., Smith, A. G., Weninger, W. and Haass, N. K. (2015). Melanoma tumor sub-populations are defined by MITF expression, and exhibit enhanced proliferation and characteristics of an EMT. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623

Thesis

Mill, Sheena (2023). Enhancing ER stress induced apoptosis and immunogenic cell death in melanoma. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/cc77375
Australian Aboriginal Flag Torres Strait Islander Flag UQ acknowledges the Traditional Owners and their custodianship of the lands on which UQ is situated. — Reconciliation at UQ
  • Media

    • Media team contacts
    • Find a subject matter expert
    • UQ news
  • Working at UQ

    • Current staff
    • Careers at UQ
    • Strategic plan
    • Staff support
    • IT support for staff
  • Current students

    • my.UQ
    • Programs and courses
    • Key dates
    • Student support
    • IT support for students
  • Library

    • Library
    • Locations and hours
    • Library services
    • Research tools
  • Contact

    • Contact UQ
    • Find a researcher
    • Faculties, schools, institutes and centres
    • Divisions and departments
    • Campuses, maps and transport
    • Media team contacts
    • Find a subject matter expert
    • UQ news
    • Current staff
    • Careers at UQ
    • Strategic plan
    • Staff support
    • IT support for staff
    • my.UQ
    • Programs and courses
    • Key dates
    • Student support
    • IT support for students
    • Library
    • Locations and hours
    • Library services
    • Research tools
    • Contact UQ
    • Find a researcher
    • Faculties, schools, institutes and centres
    • Divisions and departments
    • Campuses, maps and transport
Web login
  • © The University of Queensland
  • ABN: 63 942 912 684
  • CRICOS: 00025B
  • TEQSA: PRV12080
  • Privacy and terms of use
  • Accessibility
  • Right to information
  • Feedback